Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

3.55
Delayed Data
As of Dec 02
 -0.02 / -0.56%
Today’s Change
2.85
Today|||52-Week Range
18.01
-77.36%
Year-to-Date
The Worst Biotech Stocks of 2016
Dec 02 / MotleyFool.com - Paid Partner Content
Down 11.7%: Is Celldex Therapeutics Now a Buy?
Nov 29 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close3.57
Today’s open3.54
Day’s range3.51 - 3.74
Volume1,834,829
Average volume (3 months)2,359,927
Market cap$359.4M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+0.76%
Earnings growth (this year)+1.34%
Earnings growth (next 5 years)--
Revenue growth (last year)+52.82%
P/E ratioNM
Price/Sales277.69
Price/Book1.21

Competitors

 Today’s
change
Today’s
% change
OXFDOxford Immunotec Glo...-0.16-1.07%
LNTHLantheus Holdings In...-0.05-0.54%
IMMUImmunomedics Inc+0.10+3.18%
VCYTVeracyte Inc-0.08-1.04%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$5.5M
Annual profit (last year)-$127.2M
Net profit margin-2,321.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
CFO, Secretary, Treasurer &
Senior Vice President
Avery W. Catlin
Corporate headquarters
Hampton, New Jersey

Forecasts


Search for Jobs